Publication | Open Access
Combining mesenchymal stem cells with serelaxin provides enhanced renoprotection against 1K/DOCA/salt‐induced hypertension
19
Citations
34
References
2021
Year
Combining BM-MSCs and serelaxin provided broader renoprotection over either therapy alone or perindopril and might represent a novel treatment for hypertensive CKD.
| Year | Citations | |
|---|---|---|
Page 1
Page 1